WADA 2026 Prohibited List Status (S2.2.3 Growth Hormone Fragments) AOD-9604 is named explicitly on the World Anti-Doping Agency 2026 Prohibited List under section S2.2.3 (Growth hormone, its analogs and fragments), prohibited at all times, both in-competition and out-of-competition
These guidelines are intended to ensure no athlete gains an unfair competitive advantage
At 12mg per serving, Astaxanthin+ reaches the upper end of the dosing range used across human studies investigating skin health, exercise recovery, visual performance, cognition, and sleep quality.1 2 3 4 7 8 9 In other words, it isn't just a high dose on paper it closely mirrors the amounts researchers have used to study some of astaxanthin's most promising benefits
Product Attributes CAS # : BPC-157: 137525-51-0
Metabolomics in prediabetes and diabetes: a systematic review and meta-analysis